Skip to main content
Fig. 1 | Critical Care

Fig. 1

From: Blood purification therapy with a hemodiafilter featuring enhanced adsorptive properties for cytokine removal in patients presenting COVID-19: a pilot study

Fig. 1

IL-6 and SOFA score variations overtime. IL-6 (a) and SOFA score (b) at baseline, at 24 h, 48 h, and 72 h of treatment initiation and immediately after the EBP discontinuation for the entire population. *Statistical significance with respect to the baseline (p < 0.016); §Statistical significance with respect to the previous time point (p < 0.016)

Back to article page

Critical Care

ISSN: 1364-8535